BioStock: Follicum applies for extended patent for its topical formulation

Report this content

The peptide specialist company Follicum has filed an international patent application for its topical cream formulation. The application is both relevant for the company’s furthest-advanced candidate, FOL-005, which is currently undergoing a clinical phase IIa study in hair loss, but also includes the formulation as carrier for other peptide drugs intended for topical application on the skin. An approved patent would open the door to new opportunities for Follicum.

Read the full article at biostock.se:

https://www.biostock.se/en/follicum-applies-for-extended-patent-for-its-topical-formulation/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Documents & Links

Quick facts

BioStock: Follicum applies for extended patent for its topical formulation
Tweet this